One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
- DOI
- 10.4244/eij-d-23-00658
- Published
- 2024 May 20
- Container
- EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4244/eij-d-23-00658,
title = {One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.},
author = {Cao D and Vranckx P and Valgimigli M and Sartori S and Angiolillo DJ and Bangalore S and Bhatt DL and Feng Y and Ge J and Hermiller J and Makkar RR and Neumann FJ and Saito S and Picon H and Toelg R and Maksoud A and Chehab BM and Choi JW and Campo G and De la Torre Hernandez JM and Krucoff MW and Kunadian V and Sardella G and Spirito A and Thiele H and Varenne O and Vogel B and Zhou Y and Windecker S and Mehran R},
year = {2024},
journal = {EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
doi = {10.4244/eij-d-23-00658},
url = {https://doi.org/10.4244/eij-d-23-00658}
}RIS
TY - JOUR TI - One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes. AU - Cao D AU - Vranckx P AU - Valgimigli M AU - Sartori S AU - Angiolillo DJ AU - Bangalore S AU - Bhatt DL AU - Feng Y AU - Ge J AU - Hermiller J AU - Makkar RR AU - Neumann FJ AU - Saito S AU - Picon H AU - Toelg R AU - Maksoud A AU - Chehab BM AU - Choi JW AU - Campo G AU - De la Torre Hernandez JM AU - Krucoff MW AU - Kunadian V AU - Sardella G AU - Spirito A AU - Thiele H AU - Varenne O AU - Vogel B AU - Zhou Y AU - Windecker S AU - Mehran R PY - 2024 JO - EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology DO - 10.4244/eij-d-23-00658 UR - https://doi.org/10.4244/eij-d-23-00658 ER -
APA
D, C., P, V., M, V., S, S., DJ, A., S, B., DL, B., Y, F., J, G., J, H., RR, M., FJ, N., S, S., H, P., R, T., A, M., BM, C., JW, C., G, C., JM, D. L. T. H., MW, K., V, K., G, S., A, S., H, T., O, V., B, V., Y, Z., S, W., & R, M. (2024). One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. https://doi.org/10.4244/eij-d-23-00658
Source records
- pubmed · retrieved 2026-09-27T09:54:49.534Z